European Journal of Hospital Pharmacy-Science and Practice | 2021

4CPS-360\u2005Risk of malnutrition in patients with COVID-19 disease who receive oral nutritional supplements

 
 
 
 
 
 
 
 
 
 

Abstract


Background and importanceThe European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines recommend the optimisation of the nutritional status of patients with SARS-CoV-2 infection through dietary advice and/or oral nutritional supplements (SNO) These should provide about 400 kcal and a minimum of 30 g of protein per serving Aim and objectivesTo identify the risk of malnutrition in patients with COVID-19 who received SNO, the cause of it and the adequacy of the SNO according to ESPEN guidelines Material and methodsA cross sectional observational study was conducted between March and April 2020 Adult patients with COVID-19 who received SNO were included Variables collected were: age, sex, body mass index (BMI), risk of malnutrition according to GLIM criteria, phenotypic criteria (weight loss (>5% in the previous 6 months) and low BMI (≤20 kg/m2 for those aged <70 years old and ≤22 kg/m2 in the elderly)) and aetiologic criteria (low intake (≥ 7 days of hyporexia) and inflammation, type of SNO, energy and protein intake, adaptation of the oral diet, evaluation by the nutrition service and reason for the consultation) The SPSS programme (V 25 0) was used for data analysis Results162 patients were analysed 51 8% (85) were men with a mean age of 72 75±12 58 years Mean BMI mean was 27 05±4 2 kg/m2 15 2% (25) of patients presented weight loss greater and 6 7% (11) presented low BMI 92 1% (151) had low intake and all patients fulfilled the criteria for inflammation associated with the disease 22 6% (37) of the patients presented with a risk of malnutrition The SNO provided a mean of 408 4±164 06 kcal/day and all were hyperprotein, with a mean of 25 96±10 08 g of protein/day 18 3% (30) had an adapted oral diet and 16 5% (27) of the patients underwent consultation with the nutrition service, the reasons for this being: 70% (19) marked hyporexia, 18 5% (5) dysphagia and 14 8% (3) diarrhoea Conclusion and relevanceA quarter of the patients analysed presented with a risk of malnutrition Hyporexia was the main symptom In our hospital, it would be advisable to increase the caloric and protein intake of the SNO to comply with ESPEN recommendations References and/or acknowledgementsConflict of interestNo conflict of interest

Volume None
Pages None
DOI 10.1136/EJHPHARM-2021-EAHPCONF.192
Language English
Journal European Journal of Hospital Pharmacy-Science and Practice

Full Text